EBS vs QCOM · rev $1.04B vs P/E 16, rev $44.28B
Emergent Biosolutions Inc (EBS) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
EBS currently screens at market cap $416.4M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the EBS and QCOM stock pages for the full models.
Not investment advice.